NCT07224919

Brief Summary

This study aims to generate clinical evidence to substantiate performance claims for the AutoFocus 360 feature in Sonova hearing aid products. AutoFocus 360 is designed to enhance speech intelligibility by detecting the direction of incoming speech and dynamically steering the beamformer toward the talker, regardless of their position relative to the listener. Preliminary internal testing suggested potential benefits in reducing noise disturbance and improving speech clarity compared to traditional directional microphone modes, with outcomes depending on noise type, talker location, and microphone configuration. The present study will systematically evaluate sound quality and listening performance with AutoFocus 360 versus conventional fixed directional settings to support claims of improved speech understanding in noise.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
30

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Nov 2025

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

November 3, 2025

Completed
2 days until next milestone

First Posted

Study publicly available on registry

November 5, 2025

Completed
22 days until next milestone

Study Start

First participant enrolled

November 27, 2025

Completed
4 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 19, 2026

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 19, 2026

Completed
Last Updated

April 20, 2026

Status Verified

April 1, 2026

Enrollment Period

4 months

First QC Date

November 3, 2025

Last Update Submit

April 15, 2026

Conditions

Outcome Measures

Primary Outcomes (1)

  • Noise disturbance sound quality attribute

    Participants will complete an A-B paired-comparison listening task to assess subjective preference for noise disturbance between two hearing aid conditions. During testing, participants will listen to short audio recordings that vary in talker location and noise type. For each trial, participants will indicate which of the two recordings (A or B) has less bothersome background noise. The outcome measure will be the proportion of "A preferred" versus "B preferred" responses aggregated across all trials and participants. Binary preference data will be analyzed using inferential statistics.

    During a single 2-hour onsite study session

Secondary Outcomes (1)

  • Speech clarity sound quality attribute

    During a single 2-hour onsite study session

Study Arms (1)

Participant group

EXPERIMENTAL

Participants will listen to scenes of a talker speaking in two types of noise from either the front, left, rear, and right using AutoFocus360 and fixed directional microphones. Condition order is randomized between participants and masked from participants and experimenters.

Device: AutoFocus 360Device: Fixed directional microphone

Interventions

AutoFocus 360 is a feature that enhances speech intelligibility by detecting the direction from where speech is coming from relative to the hearing aid wearer and steering the beamforming towards the direction of the speech.

Participant group

Fixed directional microphones delivers static beamforming towards the front of the hearing aid wearer.

Participant group

Eligibility Criteria

Age18 Years - 99 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Adults (18-99 years)
  • Binaural, symmetric, sensorineural N2 (mild) to N5 (moderate-severe) hearing loss
  • Fluent in English

You may not qualify if:

  • Minors (\< 18 years
  • Normal hearing or hearing loss \> N6 (severe)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Sonova Canada Inc.

Kitchener, Ontario, N2E 1Y6, Canada

Location

MeSH Terms

Conditions

Hearing Loss

Condition Hierarchy (Ancestors)

Hearing DisordersEar DiseasesOtorhinolaryngologic DiseasesSensation DisordersNeurologic ManifestationsNervous System DiseasesSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

  • Jinyu Qian, PhD

    Sonova AG

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Research Scientist

Study Record Dates

First Submitted

November 3, 2025

First Posted

November 5, 2025

Study Start

November 27, 2025

Primary Completion

March 19, 2026

Study Completion

March 19, 2026

Last Updated

April 20, 2026

Record last verified: 2026-04

Data Sharing

IPD Sharing
Will not share

Locations